Previously, Li et al.[16] performed a meta-analysis of the association of these two variants in RNASEL and prostate cancer risk, which included 11 case-control studies (each study contains the frequency of genotypes), and suggested that the Asp541Glu polymorphism was associated with an increased risk of prostate cancer in Caucasians. This evidence concerns the gene RNASEL and prostate carcinoma.